Hamilton Thorne Ltd. (CVE:HTL – Get Free Report)’s share price rose 4.3% during trading on Tuesday . The stock traded as high as C$1.45 and last traded at C$1.45. Approximately 25,700 shares traded hands during trading, a decline of 27% from the average daily volume of 35,118 shares. The stock had previously closed at C$1.39.
Hamilton Thorne Price Performance
The firm has a fifty day moving average of C$1.45 and a two-hundred day moving average of C$1.45. The stock has a market capitalization of C$149.69 million, a P/E ratio of 58.94 and a beta of 0.54. The company has a debt-to-equity ratio of 16.60, a current ratio of 3.20 and a quick ratio of 2.25.
About Hamilton Thorne
Hamilton Thorne Ltd. develops, manufactures, and sells precision instruments, consumables, software, and services for the assisted reproductive technologies (ART), research, and cell biology markets. It offers precision laser systems, imaging systems, and other equipment and consumables for the ART and developmental biology research markets. The company also provides test laboratory and endotoxin testing services, as well as sperm assays, including Sperm Motility Index and Sperm Penetration; and fresh and cryopreserved mouse embryos supply, and technician training and proficiency testing services.
See Also
- Five stocks we like better than Hamilton Thorne
- The gold chart Wall Street is terrified of…
- Trump’s “Ace Card” For Iran
- Gold’s Next Surge is Imminent
- Have $500? Invest in Elon’s AI Masterplan
- What a Former CIA Agent Knows About the Coming Collapse
Receive News & Ratings for Hamilton Thorne Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hamilton Thorne and related companies with MarketBeat.com's FREE daily email newsletter.
